Avoid common mistakes on your manuscript.
Correction to: Clinical and Translational Oncology (2022) 24:1643–1656 https://doi.org/10.1007/s12094-022-02818-7
Following publication of this article, errors were identified in Fig. 4; specifically:
-
Fig. 4-2B: in the immunofluorescence of K150-BCL2-24H, the following images were originally duplicated in error:
-
Combination (second row)
-
Niraparib Tosylate (3rd row)
-
-
Fig. 4-2C: in the immunofluorescence of K30-γH2AX(24H), the following image was originally duplicated in error:
-
Radiation (1st row)
-
The images have been replaced with the correct images from the raw data.
The corrections do not have any effect on the final conclusions of the paper. The original article has been corrected.
Figure 4 (2) A Immunofluorescence of γH2AX. B Immunofluorescence of BAX. C Immunofluorescence of BCL-2. (3) mRNA relative expression level among the four groups for A KYSE-30 cell line. B KYSE-150 cell line. *P < 0.05, **P < 0.01
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Cui, Y., Huang, W., Du, F. et al. Correction to: Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study. Clin Transl Oncol 25, 560–562 (2023). https://doi.org/10.1007/s12094-022-03020-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-022-03020-5